Primary Central Nervous System Lymphomas: A Validation Study of Array-Based Comparative Genomic Hybridization in Formalin-Fixed Paraffin-Embedded Tumor Specimens

被引:48
作者
Braggio, Esteban [2 ]
McPhail, Ellen Remstein [1 ]
Macon, William [1 ]
Lopes, M. Beatriz [3 ]
Schiff, David [4 ]
Law, Mark [1 ]
Fink, Stephanie [1 ]
Sprau, Debra [1 ]
Giannini, Caterina [1 ]
Dogan, Ahmet [1 ]
Fonseca, Rafael [2 ]
O'Neill, Brian Patrick [1 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Biochem, Scottsdale, AZ USA
[3] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA
[4] Univ Virginia, Dept Neurol, Charlottesville, VA 22903 USA
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; PRIMARY CNS LYMPHOMA; B-CELL LYMPHOMAS; COPY NUMBER; DNA; PATHWAYS; GENE; CGH; ACTIVATION; DELETIONS;
D O I
10.1158/1078-0432.CCR-11-0395
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: Only a limited number of genetic studies have been conducted in primary central nervous system lymphomas (PCNSL), partly due to the rarity of the tumors and the very limited amount of available tissue. In this report, we present the first molecular characterization of copy number abnormalities (CNA) of newly diagnosed PCNSL by array-based comparative genomic hybridization (aCGH) in formalin-fixed paraffin-embedded (FFPE) specimens and compare the results with matched, frozen tumor specimens. Experimental Design: We conducted aCGH in FFPE tissues from PCNSL. Results were compared with matched, paired, frozen tumors. Results: Our analysis confirmed the good to fair quality and reliability of the data generated from limited amounts of tumoral FFPE tissue. Overall, all PCNSL cases were characterized by highly complex karyotypes, with a median of 23 CNAs per patient (range, 17-47). Overall, 20 chromosomal regions were recurrently found in more than 40% of cases. Deletions of 6p21, 6q, and 9p21.3 and gain of 12q12-q24.33 were the commonest CNAs. Other minimal affected regions were defined, and novel recurrent CNAs affecting single genes were identified in 3q26.32 (TBL1XR1) and 8q12.1 (TOX). Conclusions: The results obtained are encouraging. Larger archival tissue collections can now be analyzed to complement the still fragmented knowledge we have of the genetic basis of the PCNSL. Clin Cancer Res; 17(13); 4245-53. (C) 2011 AACR.
引用
收藏
页码:4245 / 4253
页数:9
相关论文
共 34 条
[1]
Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model [J].
Abrey, Lauren E. ;
Ben-Porat, Leah ;
Panageas, Katherine S. ;
Yahalom, Joachim ;
Berkey, Brian ;
Curran, Walter ;
Schultz, Christopher ;
Leibel, Steven ;
Nelson, Diana ;
Mehta, Minesh ;
DeAngelis, Lisa M. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) :5711-5715
[2]
Development of all CD4 T lineages requires nuclear factor TOX [J].
Aliahmad, Parinaz ;
Kaye, Jonathan .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (01) :245-256
[3]
[Anonymous], NIH PUBLICATION
[4]
Primary CNS lymphoma [J].
Batchelor, T ;
Loeffler, JS .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (08) :1281-1288
[5]
High-dose methotrexate for the treatment of primary cerebral lymphomas: Analysis of survival and late neurologic toxicity in a retrospective series [J].
Blay, JY ;
Conroy, T ;
Chevreau, C ;
Thyss, A ;
Quesnel, N ;
Eghbali, H ;
Bouabdallah, R ;
Coiffier, B ;
Wagner, JP ;
Le Mevel, A ;
Dramais-Marcel, D ;
Baumelou, E ;
Chauvin, F ;
Biron, P .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :864-871
[6]
Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways [J].
Booman, M. ;
Szuhai, K. ;
Rosenwald, A. ;
Hartmann, E. ;
Kluin-Nelemans, H. C. ;
de Jong, D. ;
Schuuring, E. ;
Kluin, P. M. .
JOURNAL OF PATHOLOGY, 2008, 216 (02) :209-217
[7]
Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenstrom's Macroglobulinemia [J].
Braggio, Esteban ;
Keats, Jonathan J. ;
Leleu, Xavier ;
Van Wier, Scott ;
Jimenez-Zepeda, Victor H. ;
Valdez, Riccardo ;
Schop, Roelandt F. J. ;
Price-Troska, Tammy ;
Henderson, Kimberly ;
Sacco, Antonio ;
Azab, Feda ;
Greipp, Philip ;
Gertz, Morie ;
Hayman, Suzanne ;
Rajkumar, S. Vincent ;
Carpten, John ;
Chesi, Marta ;
Barrett, Michael ;
Stewart, A. Keith ;
Dogan, Ahmet ;
Bergsagel, Leif ;
Ghobrial, Irene M. ;
Fonseca, Rafael .
CANCER RESEARCH, 2009, 69 (08) :3579-3588
[8]
Del(6)(q22) and BCL6 Rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course [J].
Cady, Francois M. ;
O'Neill, Brian Patrick ;
Law, Mark E. ;
Decker, Paul A. ;
Kurtz, David M. ;
Giannini, Caterina ;
Porter, Alyx B. ;
Kurtin, Paul J. ;
Johnston, Patrick B. ;
Dogan, Ahmet ;
Remstein, Ellen D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) :4814-4819
[9]
Primary central nervous system lymphoma [J].
Ferreri, Andres J. M. ;
Reni, Michele .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 63 (03) :257-268
[10]
Gerstner ER, 2010, ARCH NEUROL-CHICAGO, V67, P291, DOI 10.1001/archneurol.2010.3